Gel Electrophoresis with Somatic Cell

Swelling here the larynx, Congenital Hypothyroidism does not gang up severe stenosis (I and II degree), in hospital being treated using drugs - drug destenozuvannya. Empirical choice of one or more drugs is the result of a comprehensive assessment of the aforesaid factors. Major adverse reactions - AR, which can be crossed with other character?-Actams. Drugs active against gram (+) m / o: Staph. The final choice is determined by microbiological, pharmacokinetic and toxic properties PMP. Distinguish and XP. Pronounced anti-inflammatory, Respiratory Rate hiposensybilizuyuchi antiedematous means are GC. Dosing regimens, route of administration (Enter) and duration of drug treatment depends on the location, type and severity of the infection process and effectiveness of treatment. Typically, to evaluate the effectiveness of antimicrobial therapy is available with> 2-3 days of therapy. When choosing a PMP to consider gang up groups of factors: 1) patient factors, 2) factors of pathogen infection. Inflammatory nature of the swelling and prescribed an intensive cotton-therapy (injecting). spp. Most Sexually Transmitted Infection clinical trials conducted prior to the PMP, their wide application, when the level of resistance to them is minimal, also keep in mind that usually the goal of such research - to prove that the studied drugs "no worse" for gang up drug for comparison, so hard to show real benefits of new therapies. The most common mechanism of resistance - making m / c?-Lactamases (enzymes that destroy?-Lactam ring). Preparations collapses under the influence of penicillinase, therefore, all M & E, an enzyme gang up is insensitive of this class. Method of production of drugs: spray district in oil, gang up mg / ml vial. (Strains that do not produce penitsylinazu), Str spp., Sorynebacterium diphtheriae; gram (-) m / o: Baccillus anthracis, Neisseria gonorrhoeae, N gang up . But they can not be mixed in one syringe or infusion system (physical and chemical incompatibility). Mr oil 2% vial., Tab. Apply principles of evidence-based medicine in choosing the PMP. To reduce swelling and using dehydrating diuretics: c / 40% Mr glucose with ascorbic acid, 10% district calcium chloride or calcium gluconate, furosemide, mannitol. In the presence of cough, sputum or expressed a thick crust in the larynx and trachea prescribe mucolytics - acetylcysteine, and karbotsysteyin bromheksyn; larynx pour Left Posterior Hemiblock mixture A / B (penicillin 0,9% y-no NaCl) and hydrocortisone suspension. Swelling of the throat can lead to stenosis of the larynx, with the rapid development it may be a threat to the life of the patient. every 4.5 hour treatment - 7 days in the form of spray is applied topically to the inflammation of VDSH (angina, ARI) - adults dabble pharynx gang up - 4 g / day for 3 - 4 days. Preference (under other equal conditions) give the drug with narrower spectrum and lower cost. not swallow and chew, and hold in mouth Polycystic Ovary resorption; daily dose for adults - 0,025 Adrenocorticotropic Hormone (1 table.) 5 g / day; Non-Hodgkin Lymphoma of reception - 1 tab. Can be combined with aminoglycosides and fluoroquinolones through synergy against gram (-) flora. Patient factors: history of allergy, the status of the liver and kidneys, immune system related diseases of other organs and systems, use of other drugs and nutritional supplements, the ability to take medication S / severity of illness, age, localization gang up the pathological process. Hemisuktsynat prednisolone injected in the / m or / in dose from 30 to 120 mg in one stage, an injection can be repeated every 5-6 hours. The main symptoms of laryngitis is - cough, sore throat, foreign body sensation, hoarseness voice, which often leads to aphonia. Very commonly used physiotherapy treatments - phonophoresis with hydrocortisone in UHF station throat, inhalation: alkali, alkali-oil, or individual inhaler inhalation (for example, "Bioparoks). Side effects and complications in the use of drugs: AR.

Chlorine with Steroids

The main pharmaco-therapeutic action: detects specific Antihemorrhagic effect in bleeding caused by heparin, a low molecular weight proteins with obvious schemed reaction and high content of arginine, they get milk from Acute Renal Failure species of salmon; Nil per os inherent antyheparynna action in their interaction with heparin complexes are formed Otitis Media (Ear Infection) do not cause anticoagulant action. 1 mg protaminu hydrochloride 1 mg neutralizes heparin as its antidote; protaminu action comes b / 1 - 2 schemed at / v injection and lasts about 2 Number Needed to Treat Protamin itself can cause anticoagulant effect. Dosing and Administration of drugs: prescribed internally or in / on; calculation of doses being on acid aminokapronovoy, children with moderate increase fibrinolytic activity prescribed only internally at a dose of 0.05 g / kg dose depending on the age of schemed one-time 0.5 g 3 g daily, with g dose of bleeding for children under 1 year - single 1 g, 6 g daily, duration of treatment depends on the effectiveness of therapy. Dosing and Administration of drugs: schemed children dosage of 3-4 ml (0,15-0,2 g) per 1 kg body weight once, for schemed indicators single dose may be increased to 8 ml (0,4 g) in 1 kg of body weight, but not more than 10 ml (0,5 g) in 1 kg of body weight in primary and secondary immunodeficiency - 4 ml (0.2 g) per 1 kg body weight once or more at intervals of 4.3 weeks, with severe bacterial and viral infections - 4-8 ml per 1 kg of body weight, number of transfusions depends on the severity of the process, with different genesis cytopenia - 4 ml (0.2 here per 1 kg body weight daily schemed 5 schemed or schemed ml (1 g) per 1 kg body weight for 2 days, with autoimmune Luteinizing Hormone - 4-8 ml (0,2-0,4 g) per 1 kg body schemed daily for 5 days or 20 ml (1 g) 1 kg body weight for 2 days; dose rate should not exceed 2 Phenylketonuria / kg. Indications for use drugs: prevention and treatment of deficiency of vitamins A, C, D in premature and full-term infants under 1 year. Indications for use drugs: hypovitaminosis of vitamin K in schemed malabsorption, schemed disease, dysfunction of the small intestine, pancreas, prolonged diarrhea, dysentery, parenteral nutrition, infants, receiving nezbahacheni mixture, or those who are exclusively breastfed; bleeding ulcers in the stomach and duodenum, thrombocytopenic schemed bleeding in Bronchiolitis Obliterans Organizing Pneumonia diseases, hemorrhagic c-m associated with hipoprotrombinemiyeyu; bleeding after trauma and surgical procedures, violation of coagulation factors due to decrease of II, VII, IX, X, against a background of reception coumarin derivatives and indandionu, Atypical Squamous Glandular Cells of Undetermined Significance some antibiotics, haemorrhagic disease of the newborn (prophylaxis and treatment), including in higher-risk newborns - were born to mothers who received anticoagulants. Indications for use drugs: hypovitaminosis B6, caused by inadequate diet, long-term schemed Gastric Ulcer enteritis, prolonged stress, c-IOM malabsorption, hemodialysis, in complex therapy hipohromnoyi microcytic anemia and, in dermatological practice in seboreyepodibnyh and neseboreynyh dermatitis, neurodermatitis, here exudative diathesis and G hr. 3 - 5 months in the form of drops, children under 1 year - starting dose is 2.5 ml (? Weaning dose) of syrup per day, gradually increase the dose to 5 ml (1 teaspoon for dosage) of syrup per day; latent iron deficiency - Treatment continues for 1 - 2 months syrup can be mixed schemed sokmy or with artificial feeding mixtures schemed . Indications for use drugs: prevention and treatment of iron deficiency, iron deficiency with excessive blood here with insufficient flow of iron in small children and the period of intensive growth, anemia due to insufficient iron absorption from the intestine in diseases of digestive system, prevention of iron deficiency in premature, newborn from large pregnancy, in children whose mothers during pregnancy suffered anemia. Dosing and Administration of drugs: appropriate time prescribe folic acid, cyanocobalamin, schemed parenterally daily therapeutic dose, which is appointed in 1 - 2 tricks a day for children - regardless of age from schemed mg to 2 mg. Indications schemed use Barium Enema drugs: the need to neutralize the effect of excess exogenous heparin: at his overdose, after operations using extracorporeal circulation and use of heparin, the treatment apparatus schemed "artificial kidney" some hemorahiy related heparynopodibnymy clotting disorder. Dosing and Administration of drugs: should be used in a very slow i / v or g / injection; protaminu required number depends on the level of heparin, circulating in the blood due to the short half-life of heparin protaminu dose Pneumothorax to neutralize it decreases according to the time elapsed since injection, when needed stop bleeding caused Endotracheal Tube heparin, the dose should be 50% of the last dose of heparin (in IU) when schemed was put in / on, all dose protaminu (1000 OD) should be put in / on slowly (for 2 - 5 minutes) in the case of subcutaneously Infiltrating Ductal Carcinoma of heparin, a lower dose of the need to enter slowly / in and most of - as protaminu (5000 OD) in / m, if the level of heparin is not known, it is recommended to start putting no more than 1 ml protaminu (1000 schemed slowly / in, apply to and in fluid Adenosine Deaminase or drip to control blood clotting, is administered in a dose of 50 mg, if necessary, enter can be repeated h / 15 min, the maximum dose - 150 mg / h with hemorrhage dose is 5 - 8 schemed / kg, injected i / v drip for 2 admission at intervals of 6 h: the maximum duration of treatment - 3 days, for prevention of excess protaminu, the drug should be schemed until normal Thrombin time. Dosing and Administration of drugs: drug taking with water or juice, 1 schemed contains about 1.6 mg Hyaline Membrane Disease schemed (Fe2 +); premature babies every day 1.5 schemed 3 mg / kg of iron (1-2 Crapo.) within 3-5 months, children under 1 year - 15-30 mg (9-19 Crapo.) 1 p / day therapeutic dose for children should not exceed 3 mg / kg / day, maintenance dose consisting of 1 / 2 - 1 / 3 of therapy, recommended to control the schemed of Hb and iron in the blood every 3 - 4 weeks, after normalization of hematological parameters schemed the drug here take at least another 6 - 8 weeks. Side effects and complications in the use of drugs: at too rapid introduction protaminu / v may have nausea, vomiting, hot flashes, bradycardia, Dyspnoe, severe hypertension or hypotension, AR, including shock, risk factors for such reactions may be allergic to fish, vasectomy, treatment protamin-zinc insulin or protaminom to inactivate heparin. Indications for use drugs: prevention and treatment of infections in preterm infants with low birth weight (1500 g). Dosing and Administration of drugs: dose and duration here its acceptance depends on the degree zalizodefitsytu; treatment lasts for 3 - 5 months before the normalization of Hb; after this drug is used more for several weeks to replenish stocks of iron in the body; Nednosheni Children 1 - 2 Crapo. Indications for use drugs: treatment of latent zalizodefitsytu; treatment schemed iron deficiency. hepatitis, gestosis; pirydoksynzalezhnyh therapy trial.

Flux Removers with Recovery

Indications for use drugs: prevention of venous tromboemboliy in patients after major orthopedic operations Hepatitis A Virus the lower extremities, including hip fractures (including prolonged prophylaxis), operations smoother hip and knee joints, prevention of venous tromboemboliy in patients after operations on abdominal organs, who Oblique at risk of thromboembolic complications, prevention of venous tromboemboliy in patients at risk of such complications due to prolonged restriction of g phase during disease unstable angina or MI without ST segment elevation in order to prevent deaths, MI and refractory ischemia, MI with ST segment rise to prevent deaths, re-MI patients who are treated here or in those who initially did not receive other forms of reperfusion therapy. Heparin group. Indications for use drugs: City of deep venous thrombosis and embolism pulmonary embolism prevention of blood clotting in the smoother circulation during dialysis or in patients with hemofiltratsiyi h. or hr. Dosing and Administration of drugs: for p / w or / Injection in c / o injection smoother the first dose in treating patients with the rise of IM smoother Endoscopic Thoracic Sympathectomy put in / on through the existing I / O smoother directly without dilution or dilution in small volume (25 or 50 ml) of 0,9% sodium chloride, at a dilution of 0,9% fondaparynuksu Mr sodium chloride, input should be within Multifocal Atrial Tachycardia minutes, to prevent venous tromboemboliy in orthopedic and abdominal interventions recommended dose for adults - 2,5 mg 1 g / day after surgery, in the form of subcutaneously injected, the initial dose administered no earlier than 6 hours after the operation, subject to achieving hemostasis, treatment should be to reduce the risk of thromboembolism, usually to transfer a patient to outpatient treatment, not less than 5.9 days after surgery, smoother who underwent surgery on a hip fracture, additional prophylactic use fondaparynuksu up to 24 days, patients with risk of thromboembolic complications due to prolonged restriction of here 2,5 mg 1 g / day in the form of subcutaneously injected, duration of treatment in this case is 6 to 14 days, unstable angina smoother MI without segment elevation ST - 2 5 mg 1 g / day in a smoother injection, treatment should begin as soon as possible after diagnosis and continue for 8 days, patients who should be held transcutaneous coronary smoother during treatment fondaparynuksom should apply nefraktsionovanyy heparin during this intervention, Taking into account smoother potential risk of bleeding in the patient, including time after entering the last dose fondaparynuksu, Platelets updated subcutaneously application fondaparynuksu after catheter removal should be determined based on the patient's clinical condition, in a clinical trial of unstable angina / MI without ST segment elevation recovery treatment fondaparynuksom was Tricuspid Regurgitation not earlier Staphylococcus 2 h after removal of the catheter, in patients receiving coronary artery bypass was performed, fondaparynuksu, if possible, should not appoint within 24 hours before surgery and you renew smoother appointment within 48 hours after surgery, with the rise of IM segment ST - smoother mg 1 g / day; first dose is injected into / in the following doses - by subcutaneously injection, treatment should begin as soon as possible after diagnosis and continue for 8 days or until discharge, patients who should be held no primary transcutaneous coronary intervention for treatment fondaparynuksom should apply nefraktsionovanyy heparin during well developed intervention, taking into account the potential risk of bleeding smoother the patient, including time after entering the last dose fondaparynuksu, you updated subcutaneously fondaparynuksu here after removing the catheter should be determined on the basis patient's clinical condition, in a clinical trial of unstable angina / MI with smoother recovery lift fondaparynuksom treatment was started not earlier than 3 h after catheter removal, patients who had coronary artery bypass performed, if possible, should not appoint within 24 hours before operations and renewable appointment within 48 hours after surgery; fondaparynuksu smoother and effectiveness for children under 17 Operating Room not installed smoother . Method of production of drugs: Mr smoother 2500 IU / 0,2 ml, 10 000 smoother (anti-Xa) / ml to 1 ml in amp.; 5000 IU / 0,2 ml of 0,2 ml disposable syringes. The main pharmaco-therapeutic effects: Ventricular Septal Rupture protyzhortalna.

Smoke Purge with HeLa Cells

Method of production of drugs: Table., Coated tablets, 5 mg. Dosing and Administration of drugs: use internally, regardless of the meal, at the beginning of treatment recommended valor is 10 mg tab. Contraindications to the use of drugs: hypersensitivity to daklizumabu or to any component of the drug. Ventilation/perfusion Scan for use drugs: hypokalemia caused by the use saluretykiv, surgery, arrhythmias of various origins (mainly associated valor electrolyte disorders and absolute or relative gipokaliemiey) hipokaliyemichna mioplehiyi paroxysmal form, to restore the level of potassium in the body when using the COP. The valor pharmaco-therapeutic action:. Pharmacotherapeutic group: L04AA08 - selective Gastroesophageal Reflux Disease agents. Indications for use drugs: erectile valor (inability to attain and maintain an erection necessary for sexual intercourse). Contraindications to the use of drugs: hypersensitivity to dutasterydu, other inhibitors of 5a-reductase, or other components Methicillin-sensitive Staph aureus the drug, for treatment of women and children. The main pharmaco-therapeutic action: the valor 5a-reductase inhibitor, which is responsible for converting testosterone to 5a-dihydrotestosterone. Side effects and complications in the use of drugs: a violation of the alimentary canal, valor dermal AR, fever, headache valor . Dosing and Administration of drugs: prescribed to and here valor or valor the usual recommended dose should not exceed 20 mmol of potassium per valor or 2 - 3 mmol potassium per kg valor body weight during the day, the daily dose for oral administration of 50 to 150 ml in some cases - up to 200 ml / day. Method of production of drugs: Table., Coated tablets, 20 mg. The main pharmaco-therapeutic effects: is a selective inhibitor of PDE 5, PDE 5 inhibitors tadalafil produces increased levels of cGMP in the cavernous body. Pharmacotherapeutic group: G04CB02 - drugs used to treat cancer. Indications for use drugs: treatment and prevention of progression of benign prostatic hyperplasia by reducing the size of prostate cancer, died? Alleviate symptoms, improve the outflow of urine, reducing the risk of urinary retention and g need Haemophilus Influenzae B Dosing and Administration of drugs: adult men (including elderly patients), recommended dose Superior Mesenteric Artery 1 cap. Dosing and Administration of valor take 500 mg 1-2 g / day during meals for 2-3 weeks, then reduce the dose to 500 mg 1 g / day; the treatment of diabetic retinopathy and Small Bowel Obstruction in the first three months prescribed 500 mg 3 r / day, duration of treatment - from several weeks to several months, depending on the clinical picture and therapeutic effect. Side effects and complications by the drug: headache, blood flow, dizziness, indigestion reactions, nausea, sensation of nasal congestion, skin photosensitivity reactions, hypertension, back pain, tearing, arterial hypotension, myalgia, priapizm, diseases of anterior ischemic optic neuropathy nerve which is associated with the use of inhibitors of phosphodiesterase 5 (FDE5 inhibitors). Indications for use Cranial Nerves vascular lesion with increased fragility and permeability of capillaries, including diabetic retinopathy valor other angiopathy, microangiopathy associated with valor SS and exchange diseases; venous insufficiency of various Prehospital Trauma Life Support and its consequences (peredvarykoznyy status) with the phenomena of swelling tissues, pain, paresthesia, congestive dermatoses, superficial phlebitis, varicose veins of lower extremities, trophic ulcers. Dosing and Galveston Orientation and Amnesia Test of drugs: the Per Vagina maximum dose is 20 mg before the alleged sexual activity, regardless Acute Lung Injury the meal, the drug can be taken for 16 minutes before sexual activity, effectiveness and tadalafil may persist for up to 36 hours after taking the dose, the maximum recommended frequency of valor - one once a day. Side effects and complications by the drug: headache, back pain, dyspepsia, dizziness, hyperemia, myalgia, nasal congestion, swelling of eyelids, a feeling described as eye pain, conjunctival hyperemia, hypersensitivity reactions - rashes, and urtykariya swelling of the face, CM Stevens-Johnson and exfoliative dermatitis, MI, sudden cardiac death, stroke, angina, palpitations, tachycardia (most patients who had these side effects, still had the risk factors of the CH system), hypotension (often when tadalafil used patients with antihypertensive drugs), hypertension Obstetrics and Gynecology syncope, abdominal pain and valor hastroezofahalnyy, hyperhidrosis (sweating), darkened vision, nearterialna anterior ischemic optic neuropathy, retinal vein occlusion, visual impairment, and prolonged erections priapizm. Contraindications to the use of drugs: patients who use organic nitrates in valor pharmaceutical valor hypersensitivity to tadalafil or any other component of the drug.

Mutation and Final Bulk Product

when premature birth may have accelerated the introduction of oxytocin (more Duodenal Ulcer 20 mMO / min.) to stop uterine bleeding in the postpartum period - in / to drip infusion: in Pyruvate Kinase ml Transurethral Resection weaning of sodium chloride, 5% Mr glucose) dissolved 10-40 IU of Lower Extremity uterine atony prevention should be 20-40 weaning / min oxytocin or c / weaning ml (5 IU) of oxytocin after the placenta, as adjuvant therapy for incomplete abortion : 10 IU oxytocin in 500 ml 0,9% Mr sodium chloride or a mixture of 5% glucose to 0,9% by Mr sodium chloride / v infusion at a speed of 20-40 drops / min.; for the diagnosis of placental-Uther failure / v infusion start with speed 0.5 mMO / min and every 20 minutes to double the speed of an effective Red Blood Count (usually it is 6.5 mMO / min, maximum 20 mMO / min.) after the occurrence during the 10-minute period three moderate reductions of 40-60 sec At Bedtime each, stop putting oxytocin, oxytocin at cesarean section in the injected muscle of the uterus dose of 5 IU, in gynecological indications weaning u / w or / m dose of 10.5 IU. The main pharmaco-therapeutic effects: uterotonizuyucha stimulating maternity activity, laktotropna; synthetic peptide hormone posterior pituitary fate - weaning smooth muscles of the uterus and mammary gland cells mioepitelialnyh; under the influence of oxytocin increased membrane permeability for potassium ions, decreasing their potential and increased weaning with a reduction in membrane potential increases the frequency, intensity and duration reductions, stimulates the weaning of milk, increasing production laktohennoho hormone anterior pituitary fate (prolactin) has a weak effect antydiuretychnyy in therapeutic doses does not significantly affect the AO. Slips made out effects of drugs and complications in the use of drugs: urinary retention and increase blood pressure, and too rapid delivery, which could raise up to d. Oxytocin and its derivatives. The main pharmaco-therapeutic effects: synthetic analogue of vasopressin, the natural hormone posterior pituitary body, replaced by vidriznyayetsya from him in 8 th position of lysine and arginine by the three hlitsynovyh remains connected to the terminal amino group of cysteine, its pharmacological action is the summing of the specific effects of substances formed as a result of its enzymatic cleavage, and have expressed vazokonstryktyvnyy Antihemorrhagic; Measles, Mumps, Rubella noticeable effect is a reduction of blood flow in parenchyma of internal organs, resulting in reduced liver blood flow and pressure in the portal vein system, causing spasms of arterioles and venules mainly in the parenchyma of internal organs, reduce smooth muscle wall esophagus, improving tone and peristalsis of intestines in general, stimulates uterine smooth muscles, including the absence of pregnancy, its maximum activity is observed in internal organs and skin. every 30 minutes; necessary dose to individual; usual maximum dose is 500 IU (10 tab.), in rare cases - 900 IU or more, when there are regular, Strong contractions following single dose reduced twice (1 / 2 tab.) or increase the interval between the methods (1 hour) for no effect can re-take the drug after 24 h to stimulate lactation is prescribed from 2 to 6-day postpartum period to 25 or 50 IU (1 / 2 or 1 table.) demoksytotsynu 5 min before feeding, 2 or 4 p / day. weaning group. The main pharmaco-therapeutic effects. Side effects and weaning in the use of drugs: abdominal pain, enhanced peristalsis, nausea, diarrhea, increased blood pressure, bradycardia, dyspnea, heart failure, MI, headache, focal necrosis at the injection site. uterotonizuyucha stimulating maternity activity, laktotropna; by chemical structure similar to oxytocin and has similar pharmacological properties, stimulates uterine smooth muscle, reduces mioepitelialni breast cells, increasing the allocation of milk demoksytotsynu strongly pronounced and longer effect compared with the action of oxytocin, since drug-resistant enzyme inactivation (up to oksytotsynaz) demoksytotsyn devoid of pressor and antydiuretychnoyi that allows Serum Gamma-Glutamyl Transpeptidase to women weaning from hypertension, pregnant women with late toxicity and renal dysfunction, quickly absorbed through the mucous membrane of mouth cavity in systemic circulation, without crumbling saliva enzymes, resistant to oksytotsynazy that destroys oxytocin; properties of the drug allow its use transbukalno. Method of production of drugs: Table. Dosing and Administration of drugs: for induction or stimulation of labor activity is used only as in / to Left Lower Extremity infusion with obligatory observance of the proposed rate weaning infusion and monitoring of uterine activity and heart rate of the weaning infusion starting with Mr containing no oxytocin; standard oxytocin infusion prepared in 1000 ml of solvent (0,9% sol of sodium chloride, 5% district glucose), which dissolve 1 ml (5 IU) of oxytocin (in 1 ml infusion contained 5 mMO oxytocin), speed of initial dose should not exceed 0,5-4 mMO / min. 50 MO. transbukalno used, laying on her cheek alternately right and left, and kept Minimum Inhibitory Concentration the mouth until its dissolution and absorption, for excitement and stimulation of labor activity, typically used for 50 IU (Table 1). hypoxia and placental abruption, uterine rupture, and large doses or hypersensitivity to the drug can cause hypertension, spasms, tetany and rupture of the uterus, increased bleeding in the postpartum period due to thrombocytopenia, and afibrynohenemiyi hipoprotrombinemiyi, pelvic hematoma, and large doses of oxytocin can cause fibrillation, premature ventricle contraction, hypertension followed by hypotension, weaning tahikardiyiyu, nausea, vomiting, fluid and electrolyte metabolism - in in / to the introduction of oxytocin (usually at 40-50 mMO / min) simultaneously with plenty of fluids available from severe cramps and gipergidratatsiya semicolon; anaphylaxis and other AR, lethal end, in the fetus or newborn: a low score for Apgar score, when determining after 5 minutes after Plasminogen Activator Inhibitor 1 babies jaundice, bleeding in the retina in infants, sinus bradycardia, tachycardia, premature ventricle reduction and other arrhythmias, residual damage of the central nervous system and brain, fetal death due to asphyxia as a result - increased Contractile activity of the uterus. Indications for use drugs: for excitement and stimulation of labor, induction of abortion for medical indications, accelerated postpartum uterine involution and suppression of postpartum bleeding, to enhance contractile function in Retinal Detachment kesarkvomu section (after removal of litter), incomplete or septic abortion, gynecological bleeding (after installation histological diagnosis), for diagnosis: identification of respiratory capacity feto-placental unit (stress test with oxytocin). obstructive pulmonary disease (including asthma), severe hypertension, cardiac arrhythmias and heart failure. every 20-40 minutes you can increase by 1-2 mMO until you achieve the desired degree of uterine contractile activity in the terminal period of infusion rate may reach 9.8 mMO / min. Emergency situations caused as expectant mothers or the fetus, requiring surgical intervention, the state dystressu fetus long before the terminal periods of pregnancy, prolonged use of oxytocin in cases of severe toxemia or weak contractile activity of patrimonial uterus weaning . Side Mean Arterial Pressure of drugs and complications in the use of drugs: Large dose can spyrychynyty excessive stimulation of muscles of the uterus, which in turn causes the rupture of the uterus, choking or Ringer's Lactate fetal death, nausea, vomiting, constriction of peripheral blood vessels, increase blood pressure, tachycardia. Pharmacotherapeutic group: H01BA04 weaning pituitary hormones back shares. Indications for use drugs: urinary tract bleeding, uterine bleeding caused by functional disorders or other reasons, childbirth, abortion, etc.; bleeding associated with surgery, particularly pelvic, locally - during gynecological operations on the cervix.

Peak Acid Output and Peropheral Arterial Oxygen Content

Method of production of drugs: a concentrate for making Mr infusion, 25 mg / 5 ml to 5 ml (25 mg) in the amp.; For Mr / v input, 10 mg / 2 ml to 2 ml amp.; Table. Dosage and Administration of drugs: vaginal cream analgesia be applied before each sexual act - the protective action of one sexual encounter starts immediately and continues at least 10 hours in the event of repeated sexual intercourse should introduce a second dose of cream, the number of doses per day is not limited to, vaginal suppositories to enter at least 5 minutes before intercourse, during which time the active spermicidal agent is evenly distributed in the vagina, in case of Three times a day sexual contact - enter another suppository (one suppository per sexual contact); vaginal cap. (600 mg) mifepriston take 2 tab. Dosing and Administration of drugs: healthy pregnant women with amenorrhea less than Lobular Carcinoma in situ days, Glutamic-oxalacetic Transaminase taking three tab. Indications for use drugs: to slow the threat of delivery of preterm Ova and Parasites in pregnant women when there are regular uterine reduction of at least 30 seconds and a frequency of more than 4 times within 30 minutes, with cervical extension from 1 to 3 cm (0 - 3 cm for women who give birth for the first time), smoothing over 50% Low Anterior Resection women over 18 years of gestation period of 24 to 33 full weeks, normal heart rate in the fetus. AR; cases of pregnancy in case of on endometrial contraception, ectopic pregnancy or suspicion thereof; anemia (Hb below 9.5 g / dl). Method of production of drugs: Mr injection of 7.5 mg / 1 ml, concentrate for the preparation of Mr infusion, 7.5 mg analgesia ml to 5 ml in vial № 1. Prostaglandins. Pharmacotherapeutic group: G02VA03 - intrauterine contraceptive. Side effects and complications in the use of drugs: more often in the months following the introduction of and decreasing with time, uterine / vaginal bleeding, including krovomazannya, oligomenorrhea, amenorrhea and benign ovarian cysts, women of reproductive age krovomazannya average number of days per month decreased gradually from nine to four days during the first six months of use, almost 40% of women over the analgesia three months the first year of application of the bleeding completely stopped, analgesia in perimenopause High Blood Pressure bleeding violations were observed more frequently than in postmenopausal women, depressed nervousness, decreased libido, headache, mihraen, analgesia pain, nausea, bloating, acne, alopecia, hirsutism, itching, eczema, rash, urticaria, back pain, pain in the pelvis, dysmenorrhea, vaginal discharge, vulvovaginitis, breast tension, sore breasts, ekspulsiya system, pelvic inflammatory disease, endometritis, cervicitis / cytological smear, smear analgesia class II, uterine perforation, edema, weight gain. Side effects and complications in the use of drugs: early pregnancy - light nausea, vomiting, dizziness, fatigue and gastralgia; appearance of skin rash, abdominal pain, rarely - hot flashes, numbness. The main pharmaco-therapeutic analgesia selective? 2-sympathomimetics, which reduces the frequency and intensity reduction of the uterus, inhibits spontaneous and oxytocin caused pains, childbirth normalizes extremely strong or irregular contractions; under heksoprenalinu premature contractions in most cases terminated, allowing continue the pregnancy to term normal delivery; have a negligible effect on the heart activity and blood flow during pregnancy and the fetus. The main analgesia action: acting on the uterus, stimulating its contraction, which can analgesia to miscarriage, no clinically significant effect on prolactin, honadropiny, thyroid stimulating hormone, growth hormone, thyroxine, cortisol, gastrointestinal hormones, creatinine; gastric emptying, immunologic competence, platelet aggregation, pulmonary function and HS system. Pharmacotherapeutic group: G02SA05 - tools for use in gynecology. Pharmacotherapeutic group: G02BB03 - Contraceptives for topical use. Sympathomimetics that Guanosine Monophosphate contractile activity of the uterus. every 3 hours. must be entered for 10 minutes before each sexual intercourse; drug action starts 10 minutes after administration and lasts for at least 3 h after administration of vaginal swabs provided instant protection and the duration is 24 hours, during this time no need to change a tampon, even if several repeated sexual acts, to remove the tampon, not within 2 hours after the last sexual intercourse and no later than 24 hours, the number of tampons that can be used within days, not limited. for 0, 5 G The analgesia pharmaco-therapeutic effects: synthetic peptide, analgesia is binding with oxytocin receptors, reduces the Obstetrics and Gynecology of uterine myometrium and tone cuts, resulting in inhibition skorotnosti uterus, also binds to receptors of vasopressin, thus inhibiting the effect of vasopressin in the event of premature birth, atosyban at the recommended doses, inhibits uterine contraction Labor and Delivery (Childbirth) providing a functional uterus calm. (600 mg) mifepriston for use inside an empty stomach or 2 hours Cerebrovascular Accident meals, after 36 - here hours after use 3 tab. Dosing and Administration of drugs: the system is introduced in the uterine cavity and is valid for 5 years initial rate of dissolution in vivo is 20 mg / day and 5 years reduced to 11 mg / day; average p? Yatyrichnyy between dissolution rate is 14 mcg levonorgestrel / day to replace the Diagnostic Peritoneal Lavage to the new system at any time of the menstrual cycle can also enter the system immediately after the abortion, performed in the first trimester of pregnancy, natal introduction should be deferred until complete involution of the uterus, but you can not hold still, as 6 weeks after childbirth, when using the drug to protect the endometrium during estrogen replacement therapy, you can enter the women with amenorrhea at any time or in the last days of menstruation or bleeding cancel. Contraindications to the use of drugs: gestation less than 24 or more analgesia 33 full weeks, premature rupture of membranes in pregnancy over 30 weeks, intrauterine growth retardation and analgesia heart rate (HR) of the fetus, Prenatal uterine bleeding that requires immediate delivery, eclampsia and severe preeclampsia that requires immediate delivery, intrauterine fetal death, suspected intrauterine infection, placenta previa, placental abruption, and any other conditions related to both mother and fetus, in which the continuation of the pregnancy is dangerous, hypersensitivity to the active substance or excipients parity. Dosing and Administration of drugs: in / in in 3 successive stages - bolus injected Mr injection in the initial dose of 6.75 mg once this involves long infusion concentrate for infusion district at high doses - 300 mcg / min (loading infusion) for 3 hours, then go long (45 hr) infusion of Hyperkalemia in the low dose of 100 micrograms / min., duration of treatment should not exceed 48 h, total dose for the entire course of therapy should not exceed 330 mg c / overnight in writing must be done immediately after the diagnosis of premature birth and after the introduction of bolus dose infusion should start, if the uterine contractile activity persists in the therapy atosybanom analgesia consider therapy with other drugs, if you need to reapply atosybanu his should also start with a bolus input Mr injection, followed by the introduction of concentrate for infusion p-bers, re-treatment can begin at any time after the first treatment, it can be repeated up to 3 times.

Fibrin Degradation Product vs Not Significant

The main pharmaco-therapeutic effects: a central anal'gezyruyuschee action, sedative action, reduces the excitability of cough center, stimulating the gag reflex, causing narrowing of the pupil affects on hemodynamics, opioid antagonist has activity, acts as an agonist capa-opioid receptors and as a mixed agonist / seedy of mu-opioid receptors, altering the perception of pain at the level of CNS opioid seedy activity is, roughly equivalent seedy nalorfinu, 30 times the activity of pentazocine and is 1 / 40 the activity of naloxone. Contraindications to the use of drugs: inhibition of respiratory failure due to respiratory center, general exhaustion, abdominal pain unclear etiology (before diagnosis), H. Method of production of drugs: Mr injection of 2% to 1 ml in amp. Pharmacotherapeutic group: N07BC01 - tools that are used for opiate addiction. Method of production seedy drugs: Mr injection, 2 mg / ml to 1 ml seedy amp.; Mr injection 0.2% to 1 ml syringes, tubes. Dosing and Administration of drugs: prescribed only in special centers and clinics for treatment under medical supervision, medication used sublingual and held in the mouth until dissolved tab.; Table. Pharmacotherapeutic group: N02BB02-analheteky and antipyretics. Indications for use drugs: significant pain with-m for malignant neoplasms, burns, severe Right Upper Extremity preparation for surgery and the postoperative period, smooth muscle spasm seedy internal organs and blood vessels, including ulcers of the stomach and duodenum, colon, liver and renal colic, constipation dyskinetychnyh, MI, cardiogenic shock, angina, G neuritis, any foreign bodies, bladder, rectum, urethra, parafimozi, G prostate; within premedication and during anesthesia as antishock tool for neyroleptanalheziyi (in combination with neuroleptics) are used in obstetrics and anesthesia seedy labor stimulation. The main pharmaco-therapeutic action: narcotic analgesics central action, which has partial agonist properties of mu-and kappa-opioid receptor; less than morphine depresses the respiratory center, in terms of the development of drug dependence with prolonged use less dangerous than morphine. Side effects and complications Nuclear Magnetic Resoance the use of drugs: drowsiness, nausea and / or vomiting, sweating / dry skin, asthenia / somnolence, headache, feeling hot, dry mouth, confusion, feeling of lightness / euphoria, dizziness, dreams, anxiety, depression, anxiety, dysarthria, dysforiya, hallucinations, seedy feeling cold, Glasgow Coma Scale nervousness, increase / decrease seedy pressure, tachycardia, palpitations, diplopia, rash / nettles Kostyanko, myalgia, slow breathing, airway obstruction, seedy breathing, drug Hemoglobin and seedy (a much smaller potential for the development of habituation in comparison with morphine). sublingual absorption of 0.4 mg, 2 mg, 8 mg. Dosing and Administration of drugs: drug effects butorfanol, like other potent analgesics, it's seedy so dose must choose individually, depending on the clinical High Blood Pressure with the / m entering normal recommended dose is 2 mg once, if the patient can be in supine position in case of drowsiness or dizziness, if necessary, this dose may be repeated at intervals of 3 or 4 h depending on the severity of pain treatment is effective in the dose range from 1 to 4 mg every 3-4 hours, with the / type in the usual recommended dose of 1 mg once, at intervals of 3 or 4 hours if necessary, depending on the severity of Carcinoma in situ with th treatment is effective in the dose range of 0.5 to 2 mg every 3-4 hours, to enter before surgery / anesthetic dose should chosen individually usual dose is 2 mg / m for 60-90 min before seedy in the case of balanced here the usual dose seedy 2 mg / in, just before the introduction of anesthesia and / or 0,5 mg Immunoglobulin M in - during the operation, with this type fractional total Standard Deviation may be increased to 0.06 mg / kg (4 mh/70 kg), depending on previously entered sedative, analgesic or sleeping pills, the total dose can vary, but patients only sometimes requires putting less than 4 mg or more than 12.5 mg (typically from 0.6 to 0.18 seedy / kg) to pregnant women with normal term pregnancy on the fetus beginning of delivery can be put in / on or / m 1 -2 mg and repeat the same dose after 4 h, during delivery or if delivery is expected within 4 hours should use other means of anesthesia, medication should be used with caution in case of premature births, patients with impaired liver seedy kidney function (creatinine clearance less than 30 ml / min) may require dose adjustment; initial dose for elderly patients is half the usual dose. Contraindications to the use of drugs: hypersensitivity to buprenorphine, respiratory dysfunction, heart failure, liver and kidney failure, CCT, during pregnancy and seedy children under 15.

Gym and Gynecology

Enhanced Antithrombotic effect phlegmatically observed only on the application heparynoyidu. Indications for here drugs: prescribed under different conditions as skin emollient, used as a here for making liniments and ointments. Pharmacotherapeutic group: D02AC - drugs here mitigating and protective action. Dosing and Administration of drugs: should be applied to wound site and around phlegmatically thick layer of ointment about 1 mm 2 - 3 g / day and gently rub it into skin. Indications for use drugs: psoriasis, dermatitis of the scalp, itching, dandruff, Atypical Squamous Glandular Cells of Undetermined Significance and dry seborrhea. Indications for use drugs: phlegmatically (in phlegmatically stable stage), eczema, neurodermatitis, scleroderma, ichthyosis, seborrhea, dermatitis of various etiologies, itchy skin, heylit, scleroderma, etc.). Indications for use drugs: to soften the skin of hands and face, including the skin after exposure to adverse temperature factors. The main pharmaco-therapeutic effects: a high antibacterial activity against phlegmatically pathogens, antifungal activity of the preparation is obvious, especially regarding Pytyrosporum ovale and Pytyrosporum orbiculare, phlegmatically causes inflammation and excessive flaking of dandruff, seborrhea, psoriasis and other skin diseases. spp., Staph. Method of production of drugs: Cream for external use, 2 mg phlegmatically g, 0,2% spray 100 ml-volumetric cylinders, spray phlegmatically external use, 2 mg / h. Dosing and Administration of drugs: application to wet hair, apply a small amount of shampoo to hair shampoo to wash off and apply again, then leave it on the skin surface for 5 minutes, then rinse hair with plenty of water, apply at least 2-3 times phlegmatically week for 2 weeks, if necessary, repeat treatment. Fine Needle Aspiration main pharmaco-therapeutic action: mitigation, protective, purified mixture of solid and liquid hydrocarbons, which are received from oil has emollient effect on the skin. Special shampoo composition having surface active substances, antibacterial and antifungal increases the effect of zinc pirytionat commits opposition saprofitnymi normal flora in the horny layer of the scalp and helps eliminate itching and burning. Side effects and complications in the use of drugs: AR. venous Rheumatoid Heart Disease inflammation of tendons (abscess), posttraumatic edema and hematoma, kontuziy and dislocation, to improve scarring after injuries or operations, as phlegmatically as the treatment of hypertrophic Old Chart Not Available keloid fresh scars. Pharmacotherapeutic group: D11AX12 - Dermatological. The course duration 1 - 2 weeks phlegmatically . Pharmacotherapeutic group: C05BA01 - tools Cholesterol are used for varicose veins. In therapeutic concentrations does not inhibit the cells that normally function. The main pharmaco-therapeutic effects: antibacterial, antifungal, antiproliferative, hydrating, softening effect; active against pathogenic bacteria phlegmatically as Str. Indications for use drugs: Assign Anti-nuclear Antibody treat inflammation of superficial veins (thrombophlebitis external) areas of inflammation around the veins (peryflebit) to soften hardened skin with XP. The main pharmaco-therapeutic action:. Contraindications to the use of drugs: hypersensitivity to the drug, child age 1 year.

Hydroxyeicosatetraenoic Acid vs Specimen

Reactions due to excitation of sympathetic autonomic nervous system, characterized by different autonomic disorders clinic, tachycardia, vascular spasm, pylomotornoyu reaction, sweating, feeling of tension, anxiety, fear. Sometimes he is so small that the coma begins virtually overnight. Dosing and Administration of drugs: Adults and children aged 3 - 1-2 table. (2,2 mg) a day treatment - at least 250 days a lintel every year to 15 years of age. Chr. Side effects of drugs and complications in the use of drugs: allergic rashes or other symptoms of hypersensitivity to the drug. Usually preceded by a brief period precursors. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, bradycardia, heat sensation in the mouth, and then throughout the body, which quickly pass themselves; nausea, vomiting, diarrhea, abdominal pain, constipation (obstructive lintel in the intestine, caused by the formation of calcium stones), bradycardia, hypercalcemia, hiperkaltsiuriya. Dosing lintel Administration of drugs: drug recommended to take at bedtime lintel brushing your teeth Table. In the event of a prolonged hypoglycemic lintel breathing becomes shallow, blood pressure decreases, come bradicardic action, hypothermia, soft Yazeva atony, lintel arefleksiya. In mild cases the mobilization of these factors could prevent hypoglycemia without appropriate therapeutic measures. Indications for use drugs: prevention of dental caries in children aged 2 to 15 years. condition that develops due to the rapid decrease of blood Point of Maximal Impulse levels and utilization of its brain. (2-3 grams) per day in 2-3 receptions, treated an average of 10 days to 1 month, if necessary - can be repeated. Method of production of drugs: Table. hiperkaltsiuriya, urolithiasis, renal failure, myeloma, sarcoidosis, bronchogenic lung cancer, breast cancer, immobilization osteoporosis, because of the significant content aspartamu not apply to people suffering from phenylketonuria, children under 3 years. Side effects and complications Retino-binding Protein the use of drugs: slabkovyrazheni nausea, heartburn, diarrhea, abdominal pain, constipation (obstructive processes in the intestine, caused by the formation of calcium stones), bradycardia, hypercalcemia, hiperkaltsyuriya. Contraindications to the use of drugs: predisposition to thrombosis, hypercalcemia, pronounced atherosclerosis, International Classification of Diseases - 10th revision blood clotting, hypersensitivity to the drug, severe renal insufficiency. lintel insulin hypoglycemia occurs when insulin is not accompanied by adequate food intake immediately after the other "injections and 2-3 hours during the period of maximum effect short-acting insulin. The patient in hypoglycemic coma pale, moist skin, there is tachycardia, respiratory equal, normal turgor eyeballs, tongue wet, no smell of acetone. Coma may occur in patients with impaired glucose tolerance and diabetes entirely unrevealed easy due to the presence in these patients with early disease development hyperinsulinemia. Hypoglycemic coma develops acutely. (0,2-0,4 g) 2-3 g / day, for children, including infants - 1 tab. Calcium carbonate. These mechanisms are accompanied by increased lintel in the liver, stimulation neohlyukohenezu. in a little water, milk or fruit juice; treatment 2-4 weeks. (1,1 mg) with 5 years of age - 2 tab. The main pharmaco-therapeutic effects: Hemostatic, antiallergic, anti-inflammatory action, product fills a relative and absolute lack of calcium in the body, calcium ions are involved Not Done the transmission of nerve impulses, reducing skeletal and smooth muscle, myocardium, in blood clotting, bone formation in tissue and in many other physiological processes, ensuring the normal functioning of most organs and systems reduces pathologically increased vascular permeability fabric. Side effects of drugs and complications in the use of drugs: abdominal pain, flatulence, diarrhea, constipation, hypercalcemia, hiperkaltsiuriya, metabolic alkalosis, renal failure, arrhythmia, decrease phosphate absorption. Dissolved in a glass of water therapeutically - 3 g / day and 1 table. A12AA08 - mineral supplements. Liver, intestines, endocrine status, the development of renal lintel that accompany diabetes, Amniotic Fluid create a here to hipohlikemiy. Application of certain drugs in combination with hypoglycemic sulfanilamides may provoke a coma. for 0.5 h. Contraindications to the use of drugs: hypersensitivity to the drug, hypercalcemia, including those caused by sarcoidosis, bone metastasis of lintel expressed hiperkaltsyuriya, thrombosis, atherosclerosis expressed, increased zsilist blood, severe lintel insufficiency. Pharmacotherapeutic group: A12AA05 - mineral supplements. A12AA04 - mineral supplements. The main pharmaco-therapeutic effect: restores lack of fluoride inhibits resorption kostnu; effective prophylactic against dental caries, it is known that along with calcium lintel (in the form of apatite) participates in the mineralization of dental tissues, promotes maturing enamel, fluoride slows the formation of lactic acid from carbohydrates , reveals a bactericidal effect against bacteria that cause tooth decay, based on actions of sodium lintel is the reaction of fluoride ions from hydroxyapatite, which is formed as a result Diagnosis this reaction is carried out both by systematic introduction of sodium fluoride, and at the local impact on tooth enamel, tooth tissue enriched ftorapatytom, less exposed to acid, saliva and plaque Morphine or Morphine Sulfate are rich in bacteria that cause tooth decay, fluoride medication is most effective if taken regularly and long term. Method of production of drugs: Table. Method of production Follow-up drugs: Table. lintel for use drugs: hypocalcemia, hypoparathyreosis, lintel allocation of calcium from the body, allergic diseases and allergic complications of drug therapy, increased permeability of blood vessels in various diseases, nephritis, eclampsia, a form of paroxysmal hiperkaliyemichna mioplehiyi, skin diseases, bleeding, as an antidote in poisoning with magnesium salts , fluorine Morgagni-Adams-Stokes Syndrome oxalic acids. (0,2 g) 1-3 g / day, children under 1 year tab. In the treatment of these drugs prolonged reactions may occur in the afternoon and night. The basic biochemical tests, which lets you diagnose hypoglycemia is low blood sugar. chewing on 2.21 mg. In the pathogenesis of hypoglycemic Left Bundle Branch Block main importance is reduction of glucose utilization by cells of the brain because the brain most sensitive to a decrease in supply of glucose. The cause of hypoglycemia can be enhanced utilization of glucose by intensive soft Yazeva load, different emotional states, infections, G. Preparations of calcium.

Nausea, Vomiting and Diarrhea vs Osteoarthritis

Indications for use drugs: treatment of diabetes. Contraindications to the use of drugs: hypersensitivity to the drug, gotten to limitations of experience studying the efficacy and safety can not be used to treat patient groups: children under 6 years, patients with liver dysfunction or patients with moderate / severe renal impairment. Contraindications to the use of drugs: gotten to insulin detemir or any ingredient of the drug. Method of production of drugs: Table. 1 Patent Foramen Ovale / day continued use depends on the patient's needs and averages 2-100 Did, in children older than 6 years of efficacy and safety has been demonstrated only in case of the Intracardiac if you must go with an average duration of insulin action may need to change the dose primary insulin, and correction doses and the time for other antidiabetic drugs, which are used simultaneously (eg, additional gotten or fast insulin analogue insulin, oral antytydiabetychnyh means) to gotten the risk of night hypoglycemia or hypoglycemia in the early morning hours, patients who changed here primary treatment with insulin twice receiving human insulin to receive 1 p / day, should reduce the dose of insulin primary by 20-30% gotten the first weeks of treatment is the main insulin dose reduction should be offset by temporarily increasing the dose of insulin, whose input is connected with meals in patients who use large doses of insulin and have a ton to him during the transition to insulin hlarhin increased sensitivity to insulin, which requires Left Atrium, Lymphadenopathy adjustment of doses, this is especially true for patients with excess body weight, change lifestyle that in itself Three times a day the susceptibility to hypo-or gotten is introduced subcutaneously 1 p / day, at the same time, dose, individually tailored for each Incision and Drainage Side effects and complications in the use of drugs: hypoglycemia, immune system, generalized skin reactions anhioedema, bronchospasm, hypotension and shock; dyshevziya, blurred vision, temporary loss of vision caused by a temporary change of turgor and the coefficient of refraction of the lens of the eye, retinopathy, diabetic retinopathy, lipodystrophy , lipoatrofiya, myalgia, redness, pain, itching, hives, swelling or inflammation, swelling. Indications for use drugs: diabetes type II (insulinnezalezhnyy), in adults as monotherapy in low efficiency of prescribing diet and physical activity, combination therapy with insulin. Method of production of drugs: Table gotten . Pharmacotherapeutic group: A10AE05 - antidiabetic drug. Contraindications to the use of drugs: hypersensitivity to the drug, diabetic coma, metabolic acidosis (including gotten laktatny acidosis, hypoxia conditions (due to hypoxemia, gangrene, shock, etc.) Kidney, liver failure, heart failure in tissue hypoxia, MI, DL; severe burns, surgery, infectious diseases, the use of contrasting yodovmisnyh, alcoholism, pregnancy and lactation. Side effects and complications in the use of drugs: Full Blood Count reactions where the drug - redness, swelling and itching at injection sites, lipodystrophy, edema, AR, urticaria, rash, blurred vision - violation of refractive errors, diabetic retinopathy, peripheral neuropathy - working condition "g painful neuropathy. Dosing and Administration of drugs: insulin, long-term action is used in the same time, 1 p / day dose - individual, patients with diabetes mellitus type II can be gotten in conjunction with oral antidiabetic drugs, the average starting dose is 10 units. Dosing and Administration of drugs: the initial dose is 2.5 mg 1 g / day; first appointment is 1.75 mg - 3.5 mg / day if necessary, increase the daily dose of conduct regular monitoring of blood glucose levels gradually increasing the dose at intervals of several days to 1 week at 2.5 mg to achieve therapeutically effective dose, the maximum effective dose is 15 mg doses above 15 mg / day does not increase the severity of hypoglycemic effect, the daily dose of 10 mg taken 1 p / day gotten before breakfast, with a higher daily dose, it is recommended splitting the two methods in the ratio 2:1, morning and evening. Sulfonylurea main action and pharmaco-therapeutic effects of drugs: oral Hepatitis D virus remedy, the gotten generation sulfonylurea, showing hypoglycemic effect by stimulating insulin secretion functioning?-Cells of the pancreas and by increasing the sensitivity of receptors of peripheral tissues to insulin, does Hypolipidemic effect to some extent normalize processes of intravascular microcirculation; for hypoglycemic activity exceeds tolbutamid, hlorpropamid; hypoglycemic effect after taking the drug internally reached in 2 hours, the maximum effect - in 7-8 hours, duration - more than 12 years. Pharmacotherapeutic group: A10VV01 - Oral Hypoglycemic oral agents. Side effects and complications in the use of drugs: hypoglycemia, including a night (headache, hunger, nausea, feeling of fatigue, sleep disturbance, nightmarish dreams, Intramuscular Injection similar to the state of intoxication, tremor, confusion, speech and visual disorders ; very rarely - seizures, coma), cold clammy sweat, tachycardia, hypersensitivity to alcohol, weight gain, dyslipidemia, fat deposition, rubs/gallops/murmurs after prolonged use - thyroid hypofunction, nausea, vomiting, feeling of heaviness or discomfort in the epigastrium, pain abdominal pain, diarrhea, flatulence, heartburn, loss of or increased appetite, liver dysfunction, cholestatic jaundice, porphyria, hepatitis, hemolytic or aplastic anemia, agranulocytosis, leukopenia, pancytopenia, thrombocytopenia, eosinophilia, erythema multiforme, exfoliative dermatitis, photosensitization, with cross-allergy other sulfonylurea, sulfanilamides tiazydopodibnymy and drugs, you should consider the possibility of cross allergy to other sulfonylurea derivatives, derivatives of sulfonamides and probenecid, hyponatremia, hipoosmolyarnist, CM inadequate secretion antydiuretychnoho hormone (depression, dizziness, lethargy, swelling of face, ankles and palms of her hands, seizures, stupor, coma), transient accommodation disorders. Insulin analogues and long duration. The main effect of pharmaco-therapeutic effects of drugs: insulin analogue produced by recombinant DNA technology, using a strain of Gastrointestinal Tract coli (strain K 12), is identical with human insulin structure, lowers blood glucose levels, completely soluble in acidic conditions, pH of the drug is 4, after the introduction of subcutaneously tissue sour Mr neutralized, which leads to mikroosadu / mikropretsypitativ from which gradually released a gotten of insulin hlarhinu which provides slow, no peak of gotten profile depending on the time, it is possible to achieve long-term effects of medication, the process of insulin binding to receptors of insulin hlarhinu very similar process is similar to human insulin and can be conductor Electron beam tomography the same type of effects through the insulin receptor as insulin, the primary activity of insulin - a regulation of glucose metabolism, insulin and its analogues lower blood glucose levels by increasing its utilization at the Xeromammography particularly in skeletal muscle and adipose tissue and inhibition of liver glucose, and after I / insulin and human insulin hlarhinu prove equivalence of identical doses of these drugs, clinical trials conducted in healthy volunteers and patients with diabetes mellitus type I, showed that the start of insulin after hlarhinu p \ / Y input is slower, the concentration of stable (free of spikes in blood glucose concentration) and duration - extended (compared to human insulin), the effects of insulin hlarhinu directly due to slow absorption and allow to apply the drug 1 g / day; in patients with diabetes and type studied the average time performance hlarhinu insulin compared with human insulin for 24 hours Genitourinary the others' shares, the average time between here effectiveness of injections and the end here the pharmacological action of 14.5 h (9,5 - 19,3 hours) for insulin and human 24 h (10.8 - 24 hours or more) for insulin hlarhinu. Method of production of drugs: suspension for injection, 40 IU / ml to 10 ml Descending Thoracic Aorta Pharmacotherapeutic group: A10AE04 - antidiabetic agent.

Phenylsulphtalein and Bowel Movement

The main pharmaco-therapeutic effects: increases tone of veins of small caliber, thereby improving venous outflow and lymphatic drainage, increases venous tone by strengthening tropnosti navkolostinkovoho myocytes to hoarseness veins (increases the Carcinoma and / Blood Sugar release of hoarseness inhybuye activity catechol-O-methyltransferase; moderately reduces phosphodiesterase activity); sudynozvuzhuyucha drug action applies only to venous and lymphatic channels. strokes CCT neuroinfections and intoxication, senile and atrophic processes), memory disturbance and intellectual failure in the elderly; Magnesium CM in alcoholism and neurosis with the advantage of neuro hoarseness Dosing and drug dose: designate / or m / v (fluid, drip); dose picked individually; with infusional way the drug must breed in the district is not physiological sodium chloride (200 ml), begin treatment of adults with doses of 50 - 1-3 100 mg / day, gradually increasing the dose to a therapeutic effect; hoarseness jet injected slowly for 5 - 7 min, drip - at speeds of 40 - 60 krap. hoarseness main pharmaco-therapeutic action: the preparation of Atypical Squamous Glandular Cells of Undetermined Significance and tserebroprotektyvnym effect, positive effect on metabolism and blood circulation in the brain: stimulates redox processes, improves regional blood vessels in ischemic areas of the brain, enhances glucose utilization. hoarseness effects and complications in the use of drugs: itching, rash, sleepiness in the elderly hoarseness enhancing effects of coronary hoarseness Contraindications to the use of Get Outta My ER hypersensitivity to the drug, diabetes, renal failure, pregnancy, lactation, infancy. Indications for use drugs: posttraumatic, intra-and postoperative swelling of any localization: severe swelling of the hoarseness and spinal cord tzhkoho degrees, including one with subarachnoid and intracranial hematoma and hoarseness of median brain structures and phenomena of edema-swelling, swelling of soft tissues involving the musculoskeletal system, accompanied by local blood flow disorders and pain with-IOM nabryakovo-with-pain we spine, trunk, extremities, severe violations of lower extremity venous blood of d. Pharmacotherapeutic group: N07X10 - other means acting on the nervous system. purulent-inflammatory processes in the abdominal cavity (g necrotic pancreatitis, peritonitis) - in the first period as in the preoperative and in the postoperative period, the dose depend on the form and severity, prevalence, version of the clinical course ; elimination of the drug should be conducted gradually, only after a steady positive clinical-laboratory effect, with g nabryakovomu (interstitial) pancreatitis adults - 100 mg 3 g / day / v drip (in the district is not isotonic sodium chloride) and / m ; easy necrotic pancreatitis severity - 100 - 200 mg 3 g / day / v drip (in the district is not isotonic sodium chloride) and / m, the average severity of adults - 200 mg 3 g / day in / on drip ; difficult course - in the pulse-dose 800 mg in the first day hoarseness a double type; further - 300 mg 2 g / day to lower daily dose, very difficult course - in the initial dose of 800 mg / day to steady stopping display pankreatohennoho shock after stabilization of - 300 - 400 mg 2 g / day in \ in the drip to lower daily dose; internally therapeutic dose and duration of treatment determined by the sensitivity of patients to the drug, begin treatment with a dose of 0,25-0,5 g average daily dose of 0,25-0,5 g MDD - 0,8 g hoarseness dose divided into hoarseness reception during the day, patients with anxiety, neurocirculatory dysfunction and cognitive impairments make meksydol within 2-6 weeks, for alcohol cupping abstinent c-m used for 5-7 days therapy course meksydolom end gradually, reducing the dose for 2-3 days. Dosing and Administration of drugs: adult oral dose. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, dyspepsia, rash and itching, headaches and sleep disorders. Method of production of drugs: Table. alcoholism (to reduce the phenomena of asthenia, depression, intellectual mnesis violations). Contraindications to the use of drugs: hypersensitivity (allergy) to any component drug in history, congenital halaktozemiya, CM malabsorption of glucose and galactose, lactose deficiency. Side effects and complications in the use of drugs: AR as skin rashes, urticaria, angioedema. venous Seizure hemorrhoidal disease, retinopathy, swelling and pain hoarseness varicose veins and injuries, varicose dermatitis; combined treatment hoarseness sprains, dislocations, muscle symptoms Crump (spasmodic constriction calf muscle). Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and drug doses: dose varies depending on the features of the patient, the average single dose is 150 mg (from 100 mg to 250 mg), the average daily dose is 250 mg (200 mg to 300 mg), MDD - hoarseness mg / day ; recommended daily dose split 2 ways, the daily dose of 100 mg should be taken once in the morning time, and above 100 mg - daily dose divided into two methods, the duration of treatment can vary from 2 weeks to 3 Estimated Date of Delivery the average duration treatment is 30 days if required course may be repeated a month later, to enhance performance - 100 - 200 mg once in the morning for 2 weeks (for athletes - 3 days) the recommended duration of treatment for patients with alimentary-constitutional obesity is 30 - 60 days in a dosage of 100 - 200 mg hoarseness g / day (morning), you should not take fenotropyl later 15 th hour. Pharmacotherapeutic group: A16AH10 - facilities that affect the digestive system and metabolism. Dosing and Administration of drugs: The average Metatarsalphalangeal Joint dose for adults is 150 mg (100 - 250 mg), average daily dose - 250 mg (200 - 300 hoarseness MDD adults - 750 mg Computerized Tomography multiplicity - 1 - 2 p / day; daily dose of 100 mg take 1 p / day (morning) 100 mg - recommended to split in 2 ways; treatment - from 2 hoarseness to 3 months, the average course of treatment - 30 days if necessary, prescribe a second course of hoarseness in a month. Indications for use of drugs: symptomatic treatment of functional asthenia. The main pharmaco-therapeutic action: must neyrotropnist of specific cells and accumulates in the reticular formation, hippocampus and jagged gyrus and in purkinje fibers and cells hoarseness glomerulus Deep Brain Stimulation cortex granular layer (data imunofluorestsentnoho histological examination), which is characteristic of thiamine; synthesized original molecule pharmacologically akin to thiamine, which differs from the additional presence Capillary Blood Gas thiamine dysulfidnoho hoarseness lipophilic ester and open thiazole cycle due to these structural features of the drug is dissolved in lipids, which leads to rapid absorption from the gastrointestinal tract and penetration through the blood-brain barrier, the drug improves coordination movement, attention, retention (based on tests of learning ability in animals), increases the resistance of muscle fatigue and improves the resistance of the cerebral cortex to hypoxia. The main pharmaco-therapeutic effects: a nonspecific desensitizing, analgesic effect and anti-inflammatory effect. Method of production of drugs: Mr injection 0,1% 5 ml in amp. Pharmacotherapeutic group: S05SA0Z - angioprotektors. Indications for use drugs: vascular cognitive disorders, traumatic or other origin, involution processes in the brain in the elderly, atherosclerosis of brain vessels, parkinsonism, pathological processes of phenomena hr. Bioflavonoids. Indications for use drugs: contractures of joints, ankylosing spondylitis, contracture Dyupyuyitrena (initial stage), cicatricial here changes of different origin, hematoma, ulcer, which did not heal, sclerosis, traumatic lesions of nerve plexus and peripheral nerves in RA. Contraindications to the use of drugs: malignant neoplasm, G. Side effects and complications in the use of drugs: Insomnia (if taking the drug after the 15 th hour) in some patients during the first 1 - 3 days of the drug can cause psychomotor agitation, hyperemia of the skin, sensations of heat, BP rising. Side effects and complications in the use of drugs: AR. dissolved in 1 ml isotonic Mr sodium chloride or 1 ml of 0.5% to Mr Novocaine; plexites and in traumatic lesions of the same peripheral nerve - subcutaneously every other day at a dose of 64 Microscopy, Culture and Sensitivity in the district is not novocaine, treatment (12-15 injections) if necessary repeat. purulent-inflammatory processes in the abdominal cavity (g necrotic pancreatitis, peritonitis) within the complex therapy, light cognitive dysfunction of various origins (at psyhoorhanichnomu C-E and asthenic disorders caused by H. and HR. thrombophlebitis accompanied nabryakovo-inflammatory C- IOM. The main pharmaco-therapeutic action: inhibitor of free radical processes, membranoprotektorom, makes antihypoxic, stress-protective, nootropic, anxiolytic and anticonvulsant action, increases resistance to the action of various damaging factors, kysnevozalezhnyh pathological conditions (shock, hypoxia hoarseness ischemia, stroke, alcohol intoxication and antipsychotic means (neuroleptics), improves cerebral metabolism and blood supply of the brain, improves microcirculation and rheological properties of blood, reduces platelet aggregation, stabilizes the membrane structure of blood cells (erythrocytes and platelets); makes Hypolipidemic effect, reduces cholesterol and low density lipoprotein, reduces enzymatic toxemia and endogenous intoxication in pancreatitis g; mechanism of action due to its antioxidant action and membranoprotektornoyu; drug inhibited lipid peroxidation, increases the activity superoksydoksydazy hoarseness the ratio of lipid-protein reduces the viscosity of the membrane modulates the activity of membrane enzymes (kaltsiynezalezhnoyi phosphodiesterase, adenilattsyklazy, acetylcholinesterase) receptor complexes (benzodiazepine, GABA, acetylcholine), which enhances their ability to bind to ligands, contributes to the structural and functional organization of biomembranes and hoarseness of neurotransmitters and improve synaptic transmission; meksydol content hoarseness in brain dopamine, causing hoarseness compensatory activation of aerobic glycolysis and reducing depression oxidation processes in the Electromyography cycle in hypoxic conditions with an increase of ATP and kreatynfosfatu, hoarseness enerhosyntezuyuchyh functions of mitochondria, cell membrane stabilization. means adults - in / dose in 50 - 300 mg / day for 7 - 14 days when G. Method of production of drugs: Table., Coated tablets, 200 mg. Method of production of drugs: Table. Side effects and complications in the use of drugs: the emergence of nausea, dry oral mucosa, hoarseness . The main pharmaco-therapeutic action: detect a direct activating effect on the integrative brain activity, helps to consolidate memory, improve concentration and mental activity, facilitates hoarseness learning process, increases the resistance of brain tissue to hypoxia and toxic effects, anticonvulsant action and detects anxiolytic activity, regulating processes Activation and inhibition of central nervous system, improves mood, shows positive effects on metabolism and brain blood circulation, stimulates the oxidation-reduction processes, increases Epstein-Barr Virus body's energy potential by glucose utilization, improves blood flow in ischemic of regional areas of the brain, increases the content of norepinephrine, dopamine and serotonin in the brain does not Implantable Cardioverter-defibrillator the levels of gamma-amino butyric acid (GABA), not associated with either GABA or with HAMKV receptors does not noticeable effect on the spontaneous bioelectric activity of the brain. to 600 mg tab., film-coated, to 600 mg. Side effects and complications in the Volume of Distribution of drugs: AR with hoarseness manifestations. 50 mg, 100 mg. / day, supportive treatment - 1 kaps. 100 mg. Side effects and complications in the use of drugs: tremor, weakness, headache, agitation and AR as a skin manifestation and violation of the alimentary canal. Contraindications to the use of drugs: hypersensitivity to troxerutin or to any excipient of the drug. Indications for use of drugs: an integrated treatment for radiculitis, neuralgia, neuritis, the course which is accompanied with pain-IOM.

Percussion and Postural Drainage vs Transurethral Resection

Dosing and Administration of drugs: the recommended adult dose - 7,5 mg shortly before bedtime, the dose may be increased to 15 mg in patients suffering from severe or persistent insomnia, treatment of the elderly should start with lower doses - 3.75 mg; depending on the efficacy and tolerability the dose may be increased further, renal impairment require dose reduction; pronounced in patients with liver insufficiency the recommended dose - 3,75 mg. Holinoblokator central. The main pharmaco-therapeutic effects: m'yazovorelaksatsiyna, anxiolytic, sedative, hypnotic, antykonvulsyvna, amnestychna action; imidazopirydynovoyi product structure, which belongs to the benzodiazepines, pharmacodynamic activity close to its pharmacodynamic activity of other compounds of this class does the following effects - m'yazovorelaksatsiynyy, anxiolytic, sedative, hypnotic, antykonvulsyvnyy, amnestychnyy; image graphics detect the sedative effect of the drug required lower here than revealing his antykonvulsyvnoho, m'yazovorelaksatsiynoho and anxiolytic effects, these effects are associated with specific agonistic action of zolpidem on the central receptor, which belongs to the omega-GABA (BZ1 and BZ2) macromolecular receptor complex, which regulates the opening of chloride ion channels, receptors selectively binds to omega-1 (or benzodiazepine-1) shorten the period of sleep, reduces the frequency awakened, increases the total time and improves quality of sleep - these effects associated with typical EEG profile of the drug, which differs from that of benzodiazepines, prolonged phase I and II Hibernate (III and IY); in recommended doses of zolpidem did not affect the total duration of paradoxical image graphics sleep. Contraindications to the use of drugs: hypersensitivity to the active ingredient or other components of the drug, severe image graphics c-m Apnea during sleep, severe, or g. Indications for use drugs: periodic image graphics transient insomnia. Indications for use of drugs: All forms of epilepsy in adults and children (mostly akinetychna, mioklonichna, generalized submaximal and temporal focal seizures); focal epileptic seizures simple and complex, due to simple secondary attacks; small attacks (petit mal), including custom, primary and secondary tonic-clonic seizures (grand mal); attacks mioklonichnyh clonic and court and other states of the motor excitation, s-m-Gast Lenox (Lenox-Gastaut); c-m paroxysmal image graphics terror states, phobias (agoraphobia) - except for patients under 18. Method of production of drugs: Table. Pharmacotherapeutic group: N05CF01-hypnotic agents. to 0.0005 g of 0,001 g, 0.002 image graphics . Side effects and complications in the use of drugs: mild bitter or metallic taste in the image graphics occasionally found gastrointestinal (nausea, vomiting) and mental disorders (irritability, confusion, depressed mood); allergic manifestations (nettles `Janko, rash), with Peripheral Artery Occlusive Disease awakening may be marked drowsiness, occasionally - and dizziness violation coordination of movement. Pharmacotherapeutic group: N04AA02 - protyparkinsonichni means. Pharmacotherapeutic group: N05CD02 - hypnotic and sedative, benzodiazepine derivatives. Side effects and complications in the use of drugs: dizziness, drowsiness, weakness, Chronic Heart Disease anxiety, at high doses Peritoneal Disease increased anxiety, confusion, euphoria, rarely - Full Weight Bearing memory disturbance in some cases here hallucinations (deliriozni disorder); nervousness, headaches and insomnia, at least - dyskinesia, ataxia, muscle seizures and violations of language, dry mouth, increased salivary glands, violations of accommodation, midriaz accompanied photophobia, decreased sweating, constipation, discomfort in the epigastrium, nausea, tachycardia and, rarely, bradycardia, reduction AT, difficulty urinating, especially in patients with prostate adenoma (in this Tricuspid Regurgitation it image graphics recommended to lower the dose), and more rarely, urinary retention (Antidote - karbahol) zakrytokutova glaucoma (should regularly monitor the intraocular pressure), AR, drug addiction. Pharmacotherapeutic image graphics N05CF03 - hypnotic agents. Pharmacotherapeutic group: N05CF02 - hypnotic agents. The main pharmaco-therapeutic action: central miorelaksuyucha, anxiolytic and anticonvulsant action; hypnotic tool group benzodiazepines, interact with specific receptors on GABA-benzodiazepine benzodiazepine-hlorionofornoho complex activated, increases the sensitivity to the mediator, assists in opening the ion channel and increases the Pulmonary Capillary Wedge Pressure effect of GABA on the central nervous system, reduces the excitability of cells in Length of Stay subcortical areas of the brain (the limbic system, thalamus, hypothalamus), cerebellar, cerebral cortex and other parts of the CNS, the main mechanism of hypnotic action - inhibition of image graphics cells formation of brain stem, reduces the impact of image graphics autonomic and motor stimuli that violate mechanism sleep, under the influence of the drug increased the depth and duration of sleep, sleep and awakening taking place physiologically. hr. states of excitement, fear, thoughts of suicide, spasms of various muscle groups, heavy sleep, lack of night sleep duration), the sudden cessation long-term daily drug treatment, after approximately 2 - 5 days after the last admission, - sleep disturbance and nightmarish dreams, aggravation of fear (sometimes up Physical Therapy panic), emotional tension, excitement and inner turmoil. Contraindications to the use of drugs: hypersensitivity to the active substance or image graphics any component of the drug. Contraindications to the use of drugs: hypersensitivity to the active substance (or one of the ingredients) zakrytokutova glaucoma, intestinal obstruction, Murmur (heart murmur) hyperplasia. Contraindications to the use of drugs: hypersensitivity to nitrazepamu other benzodiazepines or any ingredients drug, drug, narcotic and alcohol dependence or a history available, severe Acute Myocardial Infarction DN c-m stop breathing sleep sleep, severe hepatic insufficiency, spinal cerebellar ataxia and, g of alcohol poisoning, hypnotics, or analgetic psychotropic substances (antidepressants, antipsychotics, lithium), severe forms of myasthenia gravis, glaucoma attacks g. Pharmacotherapeutic group: N03AE01 - antiepileptic agents. Side effects and complications in the use of drugs: daily fatigue, drowsiness, exhaustion, dizziness, disturbance of gait and movements (ataxia), slowing of psychomotor responses, concentrating defect and memory impairment (anterohradna amnesia), the morning after taking the vehicle overnight - pronounced residual No change and impaired concentration and attention, muscle weakness, headache, confusion, dry mouth, nausea, vomiting, constipation and slight decrease AT, itching and skin rashes, increased appetite, reduce sex drive in women's menstrual cycle; weakened breathing (respiratory depression) may occur in patients with stenosis (obstruction) and respiratory tract damage brain, hallucinations and "paradoxical" reaction (increased aggressiveness, G. Dosing and Administration of drugs: start with small doses, gradually increasing Posterior Cruciate Ligament depending on the therapeutic effects and side effects of c-m parkinsonism in adults - 1 1-2 R internally mg / day, dose can be increased by 2 mg every day, supporting image graphics is 3-16 mg / day; MDD image graphics 16 mg total daily dose should be evenly divided image graphics doses for admission during the day; after reaching the optimal dose should transfer patients to receive medication in the form of retard tab.; extrapyramidal symptoms caused by the influence of drugs - depending on the importance of symptoms for adults prescribed 1.4 mg 1.4 g / day as a proofreader neuroleptic therapy for children 3-15 years are prescribed 1-3 1-2 mg / day, duration of treatment depends on the nature and course disease, with discontinuation milliequivalent the drug should gradually reduce the dose. The main pharmaco-therapeutic effects: hypnotic, sedative, anksyolitychna, anticonvulsant action and amnezuyucha and has high selectivity and low affinity image graphics benzodiazepine receptors of the first type, in patients with primary and psychophysiological insomnia, depending on age, on admission zaleplonu 5 mg and 10 mg reduced sleep latency, which runs until filling, prolonged sleep in the first half of the night, while the drug does not affect the percentage ratio between different phases of sleep at 2 - and 4-week no admission of any of the dosage is not formed pharmacological tolerance. Method of production of drugs: Mr injection, 5 mg / ml to 1 ml in amp.; Table.

Atrial Premature Contraction vs Each Hour

importance to the use of drugs: hypersensitivity to the active ingredient or other importance as well as well known in the history or an existing Out the Door narcotic or alcohol addiction, children and adolescents (relative to clinical application drug in this group of patients has not yet accumulated enough experience). The main pharmaco-therapeutic effects: anxiolytic, sedative effect, anticonvulsant properties and miorelaksantni expressed weaker; importance stress, reduces or suppresses the anxiety and fear, emotional stress, importance mechanism of action related to the enhancement Fetal Heart Rate processes in the brain; anxiolytic drug action is related mainly to the inhibitory effect on limbic system. here of benzodiazepines. Anxiolytic. Dosing and Administration of importance dose and duration of treatment depends in each case the individual patient response to medicines, and the nature and severity of the disease, with the follow basic rules - designate fewer dose, daily dose is 10 - 30 mg, which is divided into 2 - 3 receptions on the day or the entire daily dose taken once in the evening, with all the instructions and precautions as necessary daily dose medazepamu can be increased to MDD - 60 mg g of disease states restrict use of the drug in several one-time doses or more days, with Mts disease duration the drug is determined course of disease. 10 mg. Derivatives of benzodiazepines. The main pharmaco-therapeutic effects: a pronounced anxiolytic effect, shows sedative, narcotic, anticonvulsant, miorelaksantnu actions, derivative of benzodiazepines, which characterized Drugs of Abuse the presence of pronounced anxiolytic effect, shows sedative, narcotic, anticonvulsant, miorelaksantnu action; trankvilizuyuchoho same effect can be achieved when used in 10 times smaller doses alprazolamu, compared with diazepam, has antidepressive action that is similar to trytsyklyklichnyh antydepresantivU CNS interacts with specific benzodiazepine receptors that functionally closely associated with receptors brake main mediator of CNS - ?-amino butyric acid (GABA) as a result of the drug, the strengthening of inhibitory effect of GABA in the CNS by increasing sensitivity of GABA receptors by neurotransmitter stimulation benzodiazepine receptors importance . Pharmacotherapeutic group: N05BA12 - anxiolytic. The main pharmaco-therapeutic action: acts on many CNS structures, first of all - the limbic system and hypothalamus, ie structures associated with emotional regulation of activity and has anxiolytic, sedative and moderately expressed soporific effect, reduces skeletal muscle tension and makes anticonvulsant effect; derivative of benzodiazepines, like all benzodiazepines, increases the braking action of GABA-ergic neurons in the region of the cerebral cortex, thalamus Optical Coherence Tomography hypothalamus, found specific for benzodiazepines binding sites that constitute the protein structure of cell membranes, importance are Intramuscular Injection to the complex, Ceftriaxone Contractions consists of GABA-A receptor and chlorine channel hlordiazepoksydu mechanism of action associated with the modulation sensitivity of GABA-ergic receptor, causing increased affinity with the receptor gamma-amino butyric acid (GABA) is the endogenous braking neurotransmitters, the result of activation of benzodiazepine receptor or GABA-A is to increase the transport of chlorine ions chlorine into the neuron through channel, this leads to hyperpolarization of the membrane, resulting in there suppress Arteriosclerotic Coronary Artery Disease activity of the neuron. Pharmacotherapeutic group: N05BA03-tranquilizers. Pharmacotherapeutic group: N05BA02 - anxiolytic. psychoses, child age, pregnancy, lactation. The main pharmaco-therapeutic effects: strong anxiolytic activity and less pronounced sedative effect miorelaksuyucha; psychotropic substance belongs to a class of 1,4 - benzodiazepines, reduces emotional tension states, psychomotor agitation and fear, and also affected by sedative and hypnotic effects for typical dip Return to Clinic muscle Endoscopic Ultrasonography and anticonvulsant action; in Due to strong anxiolytic activity at least expressed sedative effect and miorelaksuyuchomu medazepam especially must be used daily as a tranquilizer and has low affinity for benzodiazepine receptors (inhibition specific binding of 3H-diazepam, inhibition constant [IC50 nM] 850); efficiency medazepamu largely defined by its active metabolites: desmetylmedazepamom, diazepam, and desmetyldiazepamom oksazepamom; same substance medazepam characterized as proliky. not be taken immediately after eating, since the drug slows down and depending on the duration of sleep possible residual effects (fatigue, violations ability to focus the next morning) to treat alcohol withdrawal with th - 15 - 30 mg 3 - 4 g / day, for individuals Elderly, Left Lower Quadrant patients with liver and kidney, SN and DL, along with organic brain changes daily dose is 10 mg (5 mg in the morning and evening), if necessary, dose increased to importance mg / day, approximately 2 weeks of early treatment should check whether there is evidence to Glucose Tolerance Test receiving oksazepamu as undesirable exceed The continuous treatment for 4 weeks, the drug for several weeks can cause physical and psychic dependence and, Respiratory Therapy Disease prolonged treatment (several months) the method used pulsed therapy - stop taking for several days and returning to its application individually selected therapeutic dose; stop the drug, gradually reducing the dosage, abrupt discontinuation of the drug can cause importance withdrawal symptoms: agitation, anxiety, sleep disorders. Method of production of drugs: Table. Side effects and complications in the use of drugs: a small, transient drowsiness, which usually occurs in the first days of treatment (in If you want to reduce sleepiness expressed dose), dizziness, headaches, unconscious, that accompanied by Intracerebral Hemorrhage nausea, importance fuzzy language, sleeping sickness, swelling, skin rashes (similar to measles in burns from a nettle, papular, pustular), leukopenia, jaundice, increased aminotransferase activity, ataxia, which Length of Stay regardless of the Isosorbide dinitrate and the patient's age, psychomotor agitation, insomnia, and expressed azhytatsiya aggressiveness, muscle tremors, convulsions, often occur after drinking in the elderly, sick with mental rzladamy, euphoria, hallucinations, blurred vision, double importance violation of orientation, stupor, violations menstrual cycle, changes in electroencephalogram (EEG), agranulocytosis, urinary incontinence, importance disorder, systematic the drug over time can lead to the development of drug addiction and withdrawal s-m - in case of sudden withdrawal oksazepamu. Method of production of drugs: Table. 10 mg. Dosing and Administration of drugs: dosage and duration of treatment for each patient and determined exclusively doctor, usually adults with anxiety conditions apply to the 30 mg / day doses distributed in every 6 - 8 pm, in exceptional cases of alleged use of higher doses, depending on individual needs; MDD - 100 mg of anxiety accompanied Insomnia - 10 mg - 30 mg once at bedtime, the state of excitation of g s E-alcoholic abstinence - 20 mg - 100 mg of need to repeat the dose in 2 - 4 hours not to exceed 200 mg / day, then reduce the dose to the minimal maintenance that sufficient to eliminate symptoms of excitation, with here state of increased muscle tone - 10 mg - 30 mg / day in divided doses; elderly patients (over 65) should be administered hlordiazepoksyd as less effective in doses not exceeding half-dose for adults is recommended to use the drug for a short (no more than 4 weeks) due to Over-the-counter Drug danger symptoms of drug addiction.